1Herbst RS, Heymach Jg, Lippman SM. Lung cancer. NEngl J Med 2008; 359:1367-1380.
2Finco TS, Westwick JK, Norris JL et al. Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. J Biol Chem 1997; 272:24113-24116.
3Hanson JL, Hawke NA, Kashams D, Baldwin AS. The nuclear factor kappaB subunits RelAJp65 and c-Rel potentiate but are not required for Ras-induced cellular transformation. Cancer Res 2004; 64:7248-7255.
4Tergaonkar V, Perkins ND. p53 and NF-kappaB crosstalk: IKKalpha tips the balance. Mol Cell 2007; 26:158- 159.
5Rocha S, Campbell KJ, Perkins ND. p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor. Mol Cell 2003; 12:15-25.
6Rocha S, Martin AM, Meek DW, Per- kins ND. p53 represses cyclin Dl transcription through down regulation of Bcl-3 and inducing increased asso- ciation of the p52 NF-kappaB subunit with histone deacetylase 1. Mol Cell Biol 2003; 23:4713-4727.
7Meylan E, Dooley AL, Feldser DM, et al. Requirement for NF-kappaB signal- ling in a mouse model of lung adenocarcinoma. Nature 2009; 462:104-107.
8Folkman J, Ryeom S. Is oncogene addiction angiogenesis-dependent? Cold Spring Harb Symp Quant Biol 2005; 70:389-397.
9Weinstein IB. Cancer: addiction to oncogenes-the Achilles heal of cancer. Science 2002; 297:63-64.
10Ehrenreiter K, Kern F, Velamoor V et al. Raf-1 addiction in Ras-induced skin carcinogenesis. Cancer Cell 2009; 16:149-160.
